Safety and Tolerability of Siponimod in Patients with Secondary Progressive Multiple Sclerosis (S33.007)
Conclusions:The safety profile of siponimod appears to be in line with other S1P receptor modulators.Study Supported by:This study was funded by Novartis Pharma AG, Basel, SwitzerlandDisclosure: Dr. Fox has received personal compensation for activities with Actelion, Biogen, Genentech, Mallinckrodt, MedDay, Novartis, and Teva Neuroscience as a consultant. Dr. Fox has received research support from Novartis. Dr. Kappos has reveived personal compensation for activities with University Hospital Basel as an advisory board member. Dr. Kappos has received research support from Swiss Multiple Sclerosis Society, Swiss National Research Foundation, European Union, Gianni Rubatto Foundation, Novartis Research Foundation, and Roche Research Foundation. Dr. Bar-Or has received personal compensation for activities with Bayer, Bayhill Therapeutics, Berlex, Biogen Idec, BioMS, Diogenix, and Eli Lilly for consulting, serving on scientific advisory boards and/or as a speaker. Dr. Cree has received personal compensation for activities with AbbVie, Biogen, EMD Serono, Novartis and Shire as a consultant. Dr. Giovannoni has received personal compensation for activities with AbbVie, Bayer HealthCare, Biogen, Canbex, FivePrime, Genzyme, GlaxoSmithKline, GW Pharma, Merck Serono, Novartis, Protein Discovery Laboratories, Roche, Synthon, Teva Neuroscience, UCB, and Vertex for honoraria. Dr. Giovannoni has received personal compensation from Elsevier in a co-chief editor capacity of MS and Related Diso...
Source: Neurology - Category: Neurology Authors: Fox, R., Kappos, L., Bar-Or, A., Cree, B., Giovannoni, G., Gold, R., Vermersch, P., Pohlmann, H., Wolf, C., Dahlke, F., Wallstrom, E., Sidorenko, T. Tags: Progressive MS Therapeutics Source Type: research
More News: Brain | Cancer & Oncology | Common Cold | Disability | Headache | Hypertension | Liver | Merck | Migraine | Multiple Sclerosis | Neurology | Neuroscience | Pharmaceuticals | Study | Urinary Tract Infections | Urology & Nephrology